- Home
- GCMG vs SIBN Comparison
GCMG vs SIBN Comparison
Compare GCMG & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMG
- SIBN
- Stock Information
- Founded
- GCMG 1971
- SIBN 2008
- Country
- GCMG United States
- SIBN United States
- Employees
- GCMG N/A
- SIBN N/A
- Industry
- GCMG Finance/Investors Services
- SIBN Medical/Dental Instruments
- Sector
- GCMG Finance
- SIBN Health Care
- Exchange
- GCMG Nasdaq
- SIBN Nasdaq
- Market Cap
- GCMG 524.4M
- SIBN 557.9M
- IPO Year
- GCMG N/A
- SIBN 2018
- Fundamental
- Price
- GCMG $12.24
- SIBN $12.29
- Analyst Decision
- GCMG Hold
- SIBN Strong Buy
- Analyst Count
- GCMG 5
- SIBN 7
- Target Price
- GCMG $12.80
- SIBN $23.43
- AVG Volume (30 Days)
- GCMG 286.4K
- SIBN 505.5K
- Earning Date
- GCMG 11-08-2024
- SIBN 11-12-2024
- Dividend Yield
- GCMG 3.60%
- SIBN N/A
- EPS Growth
- GCMG N/A
- SIBN N/A
- EPS
- GCMG N/A
- SIBN N/A
- Revenue
- GCMG $462,593,000.00
- SIBN $157,035,000.00
- Revenue This Year
- GCMG $15.24
- SIBN $21.87
- Revenue Next Year
- GCMG $13.65
- SIBN $17.34
- P/E Ratio
- GCMG N/A
- SIBN N/A
- Revenue Growth
- GCMG 8.20
- SIBN 18.98
- 52 Week Low
- GCMG $8.04
- SIBN $11.70
- 52 Week High
- GCMG $12.57
- SIBN $21.70
- Technical
- Relative Strength Index (RSI)
- GCMG 60.49
- SIBN 40.52
- Support Level
- GCMG $11.40
- SIBN $12.00
- Resistance Level
- GCMG $12.43
- SIBN $12.60
- Average True Range (ATR)
- GCMG 0.40
- SIBN 0.81
- MACD
- GCMG 0.04
- SIBN -0.26
- Stochastic Oscillator
- GCMG 80.12
- SIBN 13.17
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.